FTC Urges DC Circ. Not To Prolong Endo-Impax Monopoly
The Federal Trade Commission urged the D.C. Circuit not to push back oral argument for the agency's bid to revive a case accusing Endo and Impax of splitting monopoly profits for...To view the full article, register now.
Already a subscriber? Click here to view full article